Atlas FDA

ETI-AB-HAVK PLUS

FDA premarket approval P890019/S012 · decided 2005-12-12

Approval details

PMA number
P890019
Supplement
S012
Supplement type
Special (Immediate Track)
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ETI-AB-HAVK PLUS
Generic name
Hepatitis a test (antibody and igm antibody)
Applicant
Diasorin
Date received
2005-11-14
Decision date
2005-12-12
Days to decision
28 days
Decision code
APPR
Product code
LOL
Advisory committee
Microbiology
Expedited review
No
Location
Stillwater, MN
Statement
APPROVAL FOR CHANGE IN THE MANUFACTURING PROCESS FOR THE NEUTRALIZING SOLUTION (HAV REAGENT).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
LIAISON ALDOSTERONE, LIAISON ALDOSTERONE CONTROL SET, LIAISON ALDOSTERONE CALIBRATION VERIFIERS (K130321)Diasorin2013-04-09